Skip to main content
. 2022 Feb 16;33(4):e35. doi: 10.3802/jgo.2022.33.e35

Table 2. Associations between obesity, MetS, and the risk of endometrial cancer.

BMI, metabolic phenotype No. participants Person-years No. cases HR (95% CI)* p-value HR (95% CI) p-value HR (95% CI) p-value
BMI (kg/m2)
<23 2,649,564 23,964,689.4 2,253 1
23–25 1,507,663 13,124,206.3 1,650 1.36 (1.28–1.45) <0.001
≥25 1,940,459 16,863,092.8 2,894 1.92 (1.82–2.04) <0.001
MetS
No 4,599,874 40,029,489.5 4,810 1 1
Yes 1,497,812 13,022,499.0 1,987 1.44 (1.36–1.52) <0.001 1.42 (1.34–1.50) <0.001
Per 1 increment component of MetS - - 1.17 (1.15–1.20) <0.001 1.17 (1.15–1.19) <0.001
Component of MetS
Elevated BP
No 3,930,473 34,198,779.3 4,220 1 1 1
Yes 2,167,213 18,853,209.2 2,577 1.22 (1.16–1.82) <0.001 1.21 (1.15–1.27) <0.001 1.13 (1.07–1.19) <0.001
Elevated FBG
No 4,324,091 37,644,549.6 4,650 1 1 1
Yes 1,773,595 15,407,438.8 2,147 1.19 (1.13–1.26) <0.001 1.18 (1.12–1.25) <0.001 1.10 (1.05–1.16) <0.001
High WC
No 3,636,723 31,656,013.0 3,554 1 1 1
Yes 2,460,963 21,395,975.5 3,243 1.52 (1.45–1.60) <0.001 1.49 (1.42–1.57) <0.001 1.43 (1.36–1.51) <0.001
Elevated TG
No 4,679,785 40,706,563.9 5,042 1 1 1
Yes 1,417,901 12,345,424.6 1,755 1.23 (1.17–1.30) <0.001 1.22 (1.16–1.29) <0.001 1.10 (1.03–1.16) 0.002
Reduced HDL
No 4,257,796 37,025,479.4 4,549 1 1 1
Yes 1,839,890 16,026,509.1 2,248 1.17 (1.12–1.24) <0.001 1.18 (1.12–1.24) <0.001 1.09 (1.04–1.15) 0.001

BMI, body mass index; BP, blood pressure; CI, confidence interval; FBG, fasting blood glucose; HDL, high-density lipoprotein; HR, hazard ratio; MetS, metabolic syndrome; TG, triglyceride; WC, waist circumference.

*Adjusted for age, smoking, drinking, vigorous physical activity, moderate physical activity, walking, age at menarche, age at menopause, number of children, breast feeding, oral contraceptive use, and family history of cancer; Adjusted for the variables mentioned above and BMI; Adjusted for the other components of MetS.